Nelson Roberts Investment Advisors Decreased Gilead Sciences (GILD) Position By $728,815; Digi International (DGII) Has 1.1 Sentiment

September 17, 2017 - By Henry Gaston

Digi International Inc. is a provider of mission and business-critical machine-to-machine and Internet-of-Things (IoT) connectivity services and products. The company has market cap of $248.15 million. The Firm creates connected products and deploys and manages critical communications infrastructures in a range of environments. It has a 28.39 P/E ratio. It offers four categories of hardware products: cellular routers and gateways, radio frequency (RF), embedded and network products.

Nelson Roberts Investment Advisors Llc decreased Gilead Sciences (GILD) stake by 12.31% reported in 2016Q4 SEC filing. Nelson Roberts Investment Advisors Llc sold 10,265 shares as Gilead Sciences (GILD)’s stock declined 8.05%. The Nelson Roberts Investment Advisors Llc holds 73,119 shares with $5.24 million value, down from 83,384 last quarter. Gilead Sciences now has $107.56 billion valuation. The stock increased 0.09% or $0.07 on September 15, reaching $82.36. About 12.40 million shares traded or 15.24% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since September 17, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on November, 7. They expect $2.07 earnings per share, down 23.33% or $0.63 from last year’s $2.7 per share. GILD’s profit will be $2.70B for 9.95 P/E if the $2.07 EPS becomes a reality. After $2.51 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -17.53% negative EPS growth.

Investors sentiment increased to 0.93 in 2016 Q4. Its up 0.02, from 0.91 in 2016Q3. It improved, as 106 investors sold GILD shares while 656 reduced holdings. 111 funds opened positions while 421 raised stakes. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Engineers Gate Manager Limited Partnership stated it has 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD). Palisade Capital Mgmt Ltd Nj invested in 0.03% or 10,600 shares. Shell Asset Mgmt reported 0.24% stake. Denver Limited Liability Company owns 6,448 shares for 0.02% of their portfolio. Edgewood Mngmt Ltd Co invested in 198,184 shares or 0.09% of the stock. Middleton And Ma owns 1.8% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 111,088 shares. Smithfield Trust stated it has 0.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Commercial Bank Of Montreal Can accumulated 2.20 million shares or 0.17% of the stock. Arizona State Retirement has 325,716 shares. Citadel Advsr Ltd Limited Liability Company reported 405,895 shares stake. Adams Diversified Equity Fund Inc accumulated 55,500 shares. Mesirow Financial Inv Mgmt owns 5,083 shares. Cambridge Incorporated accumulated 0.24% or 7,434 shares. Mckinley Carter Wealth Serv Inc has 4,923 shares for 0.18% of their portfolio. The New York-based Rockefeller Financial Inc has invested 0.02% in Gilead Sciences, Inc. (NASDAQ:GILD).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 88 analyst reports since July 29, 2015 according to SRatingsIntel. Morgan Stanley downgraded Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, October 2 to “Equal-Weight” rating. The firm earned “Buy” rating on Thursday, September 22 by Berenberg. The rating was upgraded by Jefferies to “Buy” on Tuesday, September 6. Maxim Group maintained the shares of GILD in report on Wednesday, October 28 with “Buy” rating. The rating was initiated by Berenberg on Monday, September 12 with “Buy”. On Thursday, February 11 the stock rating was initiated by Oppenheimer with “Outperform”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Tuesday, July 11. The rating was downgraded by Credit Suisse on Tuesday, September 5 to “Hold”. The firm earned “Overweight” rating on Thursday, November 5 by Piper Jaffray. As per Monday, August 17, the company rating was upgraded by Vetr.

Since March 30, 2017, it had 0 buys, and 7 sales for $16.39 million activity. On Thursday, June 1 Alton Gregg H sold $325,114 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,000 shares. 73,333 shares were sold by MARTIN JOHN C, worth $5.01M. Cogan John Francis had sold 9,943 shares worth $668,667 on Tuesday, May 9.

The stock increased 1.08% or $0.1 on September 15, reaching $9.35. About 152,353 shares traded or 134.67% up from the average. Digi International Inc. (DGII) has declined 12.18% since September 17, 2016 and is downtrending. It has underperformed by 28.88% the S&P500.

Ratings analysis reveals 50% of Digi Intl’s analysts are positive. Out of 2 Wall Street analysts rating Digi Intl, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. DGII was included in 2 notes of analysts from August 24, 2016. The stock has “Neutral” rating by Sidoti on Wednesday, August 24. Lake Street maintained the shares of DGII in report on Friday, January 27 with “Buy” rating.

Punch & Associates Investment Management Inc. holds 1.96% of its portfolio in Digi International Inc. for 1.43 million shares. Riverbridge Partners Llc owns 1.64 million shares or 0.47% of their US portfolio. Moreover, Edgepoint Investment Group Inc. has 0.45% invested in the company for 1.95 million shares. The California-based Globeflex Capital L P has invested 0.11% in the stock. Bowling Portfolio Management Llc, a Ohio-based fund reported 49,128 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com